Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.31p
   
  • Change Today:
      0.012p
  • 52 Week High: 0.75
  • 52 Week Low: 0.23
  • Currency: UK Pounds
  • Shares Issued: 742.80m
  • Volume: 4,842,860
  • Market Cap: £2.28m
  • RiskGrade: 435

Deal with Barclays    Trade now with Barclays Stockbrokers

Valirx Overview

ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Registrars: Capita Registrars

Key Personnel

CFO: Gerald Desler
Chief Executive Officer : Mark Eccleston
Non-Executive Chairman: Martin Gouldstone
Non-Executive Dir: Cathy Tralau-Stewart

Contact Details

Address: Stonebridge House, Chelmsford Road, Hatfield Heath, United Kingdom, CM22 7BD
Website: http://www.valirx.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BLH13C52

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Valirx Market Data

Currency UK Pounds
Share Price 0.31p
Change Today 0.012p
% Change 3.95 %
52 Week High 0.75
52 Week Low 0.23
Volume 4,842,860
Shares Issued 742.80m
Market Cap £2.28m
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
41.52% above the market average41.52% above the market average41.52% above the market average41.52% above the market average41.52% above the market average
46.34% above the sector average46.34% above the sector average46.34% above the sector average46.34% above the sector average46.34% above the sector average
Price Trend
87.83% below the market average87.83% below the market average87.83% below the market average87.83% below the market average87.83% below the market average
81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average
Income Not Available
Growth
26.62% above the market average26.62% above the market average26.62% above the market average26.62% above the market average26.62% above the market average
31.03% above the sector average31.03% above the sector average31.03% above the sector average31.03% above the sector average31.03% above the sector average

Valirx Dividends

No dividends found

Trades for 24-Mar-2026

Time Volume / Share Price
11:13 5,500 @ 0.30p
11:12 500 @ 0.32p
11:11 5,000 @ 0.32p
09:54 250,000 @ 0.31p
09:53 250,000 @ 0.31p

Valirx Key Personnel

CFO Gerald Desler

Top of Page